190 related articles for article (PubMed ID: 21424873)
1. Recurrence of hepatocellular carcinoma after living donor liver transplantation: what is the current optimal approach to prevent recurrence?
Kaido T; Mori A; Ogura Y; Hata K; Yoshizawa A; Iida T; Uemoto S
World J Surg; 2011 Jun; 35(6):1355-9. PubMed ID: 21424873
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
[TBL] [Abstract][Full Text] [Related]
3. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
[TBL] [Abstract][Full Text] [Related]
4. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
Kulik LM; Fisher RA; Rodrigo DR; Brown RS; Freise CE; Shaked A; Everhart JE; Everson GT; Hong JC; Hayashi PH; Berg CL; Lok AS;
Am J Transplant; 2012 Nov; 12(11):2997-3007. PubMed ID: 22994906
[TBL] [Abstract][Full Text] [Related]
7. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
[TBL] [Abstract][Full Text] [Related]
8. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
9. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
Na GH; Kim EY; Hong TH; You YK; Kim DG
HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
[TBL] [Abstract][Full Text] [Related]
10. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
Takada Y; Kaido T; Shirabe K; Nagano H; Egawa H; Sugawara Y; Taketomi A; Takahara T; Wakabayashi G; Nakanishi C; Kawagishi N; Kenjo A; Gotoh M; Toyoki Y; Hakamada K; Ohtsuka M; Akamatsu N; Kokudo N; Takeda K; Endo I; Takamura H; Okajima H; Wada H; Kubo S; Kuramitsu K; Ku Y; Ishiyama K; Ohdan H; Ito E; Maehara Y; Honda M; Inomata Y; Furukawa H; Uemoto S; Yamaue H; Miyazaki M; Takada T;
J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
[TBL] [Abstract][Full Text] [Related]
11. Late recurrence of hepatocellular carcinoma after liver transplantation.
Chok KS; Chan SC; Cheung TT; Chan AC; Fan ST; Lo CM
World J Surg; 2011 Sep; 35(9):2058-62. PubMed ID: 21597889
[TBL] [Abstract][Full Text] [Related]
12. Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.
Ruzzenente A; Capra F; Pachera S; Iacono C; Piccirillo G; Lunardi M; Pistoso S; Valdegamberi A; D'Onofrio M; Guglielmi A
J Gastrointest Surg; 2009 Jul; 13(7):1313-20. PubMed ID: 19418103
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria).
Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC
Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601
[TBL] [Abstract][Full Text] [Related]
14. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
Kim SH; Lee EC; Na BG; Park SJ
Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
[TBL] [Abstract][Full Text] [Related]
15. Living donor liver transplantation for hepatocellular carcinoma.
Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
[TBL] [Abstract][Full Text] [Related]
16. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
17. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
18. Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
Hsu CC; Chen CL; Wang CC; Lin CC; Yong CC; Wang SH; Liu YW; Lin TL; Lee WF; Lin YH; Chan YC; Wu YJ; Eng HL; Cheng YF
Transplantation; 2016 Sep; 100(9):1925-32. PubMed ID: 27306534
[TBL] [Abstract][Full Text] [Related]
19. Living-donor liver transplantation for hepatocellular carcinoma.
Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.
Lei J; Yan L; Wang W
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1340-6. PubMed ID: 23652915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
